Fetal Primary Cardiac Tumors During Perinatal Period
Author(s) -
ShiMin Yuan
Publication year - 2016
Publication title -
pediatrics and neonatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.569
H-Index - 36
eISSN - 2212-1692
pISSN - 1875-9572
DOI - 10.1016/j.pedneo.2016.07.004
Subject(s) - medicine , everolimus , hydrops fetalis , rhabdomyoma , fetus , fetal surgery , cardiac surgery , fetal echocardiography , sacrococcygeal teratoma , surgery , cardiology , tuberous sclerosis , pregnancy , radiology , prenatal diagnosis , in utero , genetics , biology
Fetal primary cardiac tumors are rare, but they may cause complications, which are sometimes life threatening, including arrhythmias, hydrops fetalis, ventricular outflow/inflow obstruction, cardiac failure, and even sudden death. Among fetal primary cardiac tumors, rhabdomyomas are most common, followed by teratomas, fibromas, hemangiomas, and myxomas. Everolimus, a mammalian target of rapamycin inhibitor, has been reported to be an effective drug to cause tumor remission in three neonates with multiple cardiac rhabdomyomas. Neonatal cardiac surgery for the resection of primary cardiac tumors found by fetal echocardiography has been reported sporadically. However, open fetal surgery for pericardial teratoma resection, which was performed successfully via a fetal median sternotomy in one case report, could be a promising intervention to rescue these patients with large pericardial effusions. These recent achievements undoubtedly encourage further development in early management of fetal cardiac tumors. Owing to the rarity of fetal primary cardiac tumors, relevant information in terms of prenatal diagnosis, treatment, and prognosis remains to be clarified.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom